Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul, South Korea.
Met Life Sciences Co., Ltd., Seoul, South Korea.
Sci Rep. 2021 Jun 28;11(1):13369. doi: 10.1038/s41598-021-92825-5.
Although protein-protein interactions (PPIs) have emerged as the basis of potential new therapeutic approaches, targeting intracellular PPIs with small molecule inhibitors is conventionally considered highly challenging. Driven by increasing research efforts, success rates have increased significantly in recent years. In this study, we analyze the physicochemical properties of 9351 non-redundant inhibitors present in the iPPI-DB and TIMBAL databases to define a computational model for active compounds acting against PPI targets. Principle component analysis (PCA) and k-means clustering were used to identify plausible PPI targets in regions of interest in the active group in the chemical space between active and inactive iPPI compounds. Notably, the uniquely defined active group exhibited distinct differences in activity compared with other active compounds. These results demonstrate that active compounds with regions of interest in the chemical space may be expected to provide insights into potential PPI inhibitors for particular protein targets.
尽管蛋白质-蛋白质相互作用 (PPIs) 已成为潜在新治疗方法的基础,但用小分子抑制剂靶向细胞内 PPIs 通常被认为极具挑战性。近年来,随着研究工作的不断增加,成功率显著提高。在这项研究中,我们分析了 iPPI-DB 和 TIMBAL 数据库中 9351 种非冗余抑制剂的理化性质,以确定针对 PPI 靶标的活性化合物的计算模型。主成分分析 (PCA) 和 k-均值聚类用于识别活性化合物和非活性 iPPI 化合物之间化学空间中活性组中感兴趣区域的可能 PPI 靶标。值得注意的是,独特定义的活性组与其他活性化合物在活性方面表现出明显的差异。这些结果表明,在化学空间中具有感兴趣区域的活性化合物可能为特定蛋白质靶标提供潜在 PPI 抑制剂的见解。